The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni
Open Access
- 1 January 2019
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 114, e180347
Abstract
Key words: schistosomiasis mansoni; cost of illnessKeywords
This publication has 14 references indexed in Scilit:
- Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling studyThe Lancet Global Health, 2015
- Trends in schistosomiasis-related mortality in Brazil, 2000–2011International Journal for Parasitology, 2014
- High Schistosoma mansoni Disease Burden in a Rural District of Western ZambiaThe American Journal of Tropical Medicine and Hygiene, 2014
- No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission AreaPLOS Neglected Tropical Diseases, 2014
- Cost-of-illness studies: concepts, scopes, and methodsClinical and Molecular Hepatology, 2014
- Severe forms of schistosomiasis mansoni: epidemiologic and economic impact in Brazil, 2010Transactions of the Royal Society of Tropical Medicine and Hygiene, 2013
- Treatment and education reduce the severity of schistosomiasis periportal fibrosisRevista da Sociedade Brasileira de Medicina Tropical, 2013
- Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature reviewGlobalization and Health, 2013
- Parasites and poverty: The case of schistosomiasisActa Tropica, 2010
- Human schistosomiasisThe Lancet, 2006